MRK vs AMGN
By Alex · Tickerpine
Merck & Co., Inc. vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | AMGN |
|---|---|---|
| Price | $128.66 | $358.33 |
| Market cap | $317.77B | $193.39B |
| P/E ratio | 36.2 | 24.9 |
| ROE | 18.94% | 101.32% |
| Profit margin | 13.59% | 20.96% |
| Revenue growth | 4.90% | 5.80% |
| Dividend yield | 2.64% | 2.81% |
| Beta | 0.22 | 0.42 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs AMGN in plain English
- MRK is the bigger company — about 1.6× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 24.9 vs 36.2).
- AMGN earns a higher return on equity (101% vs 19%).
- AMGN is growing revenue faster (6% vs 5%).
- AMGN has the higher dividend yield (2.81% vs 2.64%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.